Searchable abstracts of presentations at key conferences in endocrinology

ea0081p563 | Calcium and Bone | ECE2022

Analysis of bone mass and body composition in transgender men at 1 year : a follow up study

Mazoca Orozco Bruno Marcos , De Oliveira Otavio Lima , Magliari Haddad Joao Victor , Santos Livia Marcela , Alvares Leonardo

Introduction: Sex steroid hormones play a key role in bone health, however medical therapies for gender dysphoria lead to hormonal changes.Purpose: Understanding the change in bone mass and body composition is extremely important, because this treatment will be carried out over a long period of timeMethods: In a prospective study, we included 19 transgender men (female-to-male trans persons) before treatment and after 1 year of tre...

ea0081ep315 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Analysis of glycemic control in type 1 diabetes patients using flash glucose monitoring

Damas-Fuentes Miguel , Martinez Montoro Jose Ignacio , Simon Frapolli Victor , Fernadez Valero Andrea , Tinahones Madueno Francisco Jose

Introduction: Flash glucose monitoring expansion to an increasing number of patients with type 1 diabetes, coupled with its increased accuracy and ease of use, has increased available data on glycemic control in this population and allows detection of improvement areas in diabetes education and treatment.Objective: To analyze main parameters standardized by ATTD consensus (2019) in our population of patients with type 1 diabetes using flash glucose monit...

ea0050p213 | Diabetes and Cardiovascular | SFEBES2017

Genomic instability in type 2 diabetes mellitus patients from Yucatan, Mexico

Pacheco-Pantoja Elda , May-Kim Sherlin , Lopez-Rivas Victor , Manjarrez-Martin Aimee , Che-Correa Erick , Baeza-Gamboa Beatriz

Background: Genomic damage plays an important role in the pathogenesis of Type 2 Diabetes Mellitus (T2DM) and its complications. This instability increases with impaired metabolic control, and is aggravated by the presence of advance glycation-end products (AGEs) causing more cell damage. The aim of this study was to analyse the presence of genomic instability in patients with T2DM and its association with the levels of AGEs, namely glycated h...

ea0050p213 | Diabetes and Cardiovascular | SFEBES2017

Genomic instability in type 2 diabetes mellitus patients from Yucatan, Mexico

Pacheco-Pantoja Elda , May-Kim Sherlin , Lopez-Rivas Victor , Manjarrez-Martin Aimee , Che-Correa Erick , Baeza-Gamboa Beatriz

Background: Genomic damage plays an important role in the pathogenesis of Type 2 Diabetes Mellitus (T2DM) and its complications. This instability increases with impaired metabolic control, and is aggravated by the presence of advance glycation-end products (AGEs) causing more cell damage. The aim of this study was to analyse the presence of genomic instability in patients with T2DM and its association with the levels of AGEs, namely glycated h...

ea0090ep1112 | Late Breaking | ECE2023

Metabolic Control and Perinatal Outcomes According to The Planning or Lack of Planning of The Pregnancy

Fernandez Valero Andrea , Jose Simon Frapolli Victor , Generoso Pinar Marta , Molina Vega Maria , J Tinahones Francisco , Jose Picon Cesar Maria

Objectives: To analyze the data of patients seen at the Diabetes and Pregnancy Unit, assessing the frequency of pregnancy planning and whether there are differences in the degree of metabolic control before and during pregnancy, as well as in perinatal outcomes with respect to those who do not plan. All women of childbearing age with Pregestational Diabetes Mellitus(PGDM) should receive preconception counseling to optimize glycemic control, since preconception control is assoc...

ea0068p9 | Abstracts | UKINETS2019

Gastric neuroendocrine neoplasms: clinical management and outcomes in a cohort of 54 patients

Victor Alexandra , Ramage John Keith , Cope Jack , Maclean Rory , Hayee Bu , Martin Wendy , Cananea Elmie , Clement Dominique , Srirajaskanthan Raj

Introduction: Gastric NENs are increasingly being diagnosed at endoscopy. The majority of these are type 1 gastric NEN. However, around 10–20% can be type 3 or type 4 Gastric NENs.Methods: A retrospective review performed of 54 patients with gastric NENs referred to a tertiary centre during 2014 to 2019.Results: Of the 54 cases referred, 45 were type 1 gastric NENs and the 9 were type 3 Gastric NENs. Of the 45 type 1 gastric N...

ea0063p490 | Calcium and Bone 2 | ECE2019

Hyperparathyroidism – jaw tumor syndrome – differential diagnostic traps

Nechita Mirela Claudia , Tudurean-Olteanu Anca Georgiana , Costan Victor Vlad , Danila Radu , Preda Cristina , Ungureanu Maria Christina

Introduction: Hyperparathyroidism-Jaw Tumor (HPT-JT) syndrome is a rare genetic disorder bearing a germline and a somatic CDC73 mutation. The features of HPT-JT are clinically difficult to ascertain because the parathyroid disease, ossifying fibroma in the jaw and other abnormalities, often occurs asynchronously and may be diagnosed and treated separately. The association of jaw ossifying fibroma with primary hyperparathyroidism (PHPT) is typical of HPT-JT.<p class="abstex...

ea0063p838 | Adrenal and Neuroendocrine Tumours 3 | ECE2019

(131) I-MIBG therapy in metastatic paraganglioma and phaeochromocytoma: a 4-year single centre experience

Mazo Estefania Santos , Lanchas Isabel , Begona Miguel , Barrio Javier Pi , Crespo Guillermo , Moreira Manuela , Garcia-Hierro Victor , Manuel Javier Sanchez

Retrospective study of patients with metastatic/progressive pheochromocytoma (PCC) and paraganglioma (PGL) treated with (131) I MIBG in our hospital during 2015–2018 period.Methods: There are no established criteria for establishing PCC/PGL as malignant apart from de presence of metastases at diagnosis. Radionuclide therapy (131) I-metaiodobenzylguanidine (MIBG) is frequently used in this patients when surgery is not possible. Indication of MIBG tre...

ea0049ep1298 | Thyroid (non-cancer) | ECE2017

The role of 99mTc-sestamibi in amiodarone-induced thyrotoxicosis – Case report

Victor Margarida , Ferreira Ana Goncalves , Carmona Susana , Luiz Henrique Vara , Cordeiro Maria Carlos , Portugal Jorge , Santos Ana Isabel

Introduction: Amiodarone is an antiarrhythmic iodine-rich drug, known to induce thyroid dysfunction both due to its high iodine content and through amiodarone-induced thyrotoxicosis (AIT), being this latter process classified into three different types. Type 1 is associated with increased thyroid hormone synthesis; type 2 is a destructive process with thyroid hormone release and type 3 is thought to be a mixture of the former two. Since treatment options are different, there h...

ea0041ep1134 | Thyroid cancer | ECE2016

Cerebellar metastasis from follicular thyroid carcinoma

Rojas Martelo Giovani , Iglesias Lozano Pedro , Jose Diez Gomez Juan , Rodriguez Berrocal Victor , Pian Arias Hector , Jimenez Zapata Daniel

Differentiated thyroid carcinoma (DTC) is the most frequent endocrine neoplasm. Follicular thyroid carcinoma (FTC) is the second histological variant in frequency after papillary thyroid carcinoma (PTC). Cerebellar metastases from DTC are extremely rare, corresponding about 1% of all cerebellar metastases, and being the majority metastases from PTC. To the best of our knowledge there have been no reported cerebellar metastases from CFT so far. We present here the first clinica...